Related Experiment Video
Updated: Jul 17, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis]
Rafael Bandrés Gimeno1, María José Muñoz Martínez
1Servicio de Neumología, Hospital Xeral de Vigo, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España. rafaelbandres@yahoo.es
Abstract:
Allergic bronchopulmonary aspergillosis is a lung disease characterized by an immune response to several antigens of Aspergillus species. Corticosteroids are the treatment of choice in the acute phase, although some studies have shown the efficacy of itraconazole. We describe the case of a favorable, prolonged therapeutic response to voriconazole in a patient with allergic bronchopulmonary aspergillosis who did not tolerate itraconazole.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Cryptococcal Meningitis
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Allergic Drug Reactions